nach oben

CardioVascular and Interventional Radiology

Erschienen in:

01.11.2008 | Review

Cryoplasty for the Prevention of Arterial Restenosis

verfasst von: Moritz G. Wildgruber, Hermann J. Berger

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Restenosis after percutaneous transluminal angioplasty remains the limiting factor for the long-term benefit of endovascular therapies of peripheral arterial occlusive disease. Despite a variety of modifications and adjuncts to angioplasty such as bare metal stents, covered stents, and drug-eluting stents as well as a number of new technologies like laser angioplasty and cutting balloon angioplasty, restenosis rates have not been significantly affected and remain inferior to those for surgery for long lesions in the femoropopliteal segment. Cryoplasty, which combines balloon angioplasty with the application of cryothermal energy to the vessel wall, was suggested as a promising approach to prevent the formation of neointimal hyperplasia after angioplasty procedures. This review discusses the basic principles of cryoplasty, summarizes the current data on restenosis rates after cryoplasty treatment, and evaluates cryoplasty as a new treatment method to solve the problems associated with restenosis development. The results of the clinical studies suggest that cryoplasty is a feasible and safe technique in the treatment of femoropopliteal disease, however, they have failed to prove any superiority of cryoplasty over conventional angioplasty.

Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstruction. Description of a new technique and a preliminary report of its application. Circulation 30:654–670PubMed

Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1–S296PubMedCrossRef

White CJ, Gray WA (2007) Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 116:2203–2215PubMedCrossRef

Krankenberg H, Schluter M, Steinkamp HJ et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116:285–292PubMedCrossRef

Schillinger M, Sabeti S, Loewe C et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888PubMedCrossRef

Tepe G, Schmehl J, Heller S, Wiesinger B, Claussen CD, Duda SH (2006) Superficial femoral artery: current treatment options. Eur Radiol 16:1316–1322PubMedCrossRef

Post MJ, de Smet BJ, van der HY, Borst C, Kuntz RE (1997) Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation 96:996–1003

Schwartz RS, Topol EJ, Serruys PW, Sangiorgi G, Holmes DR Jr (1998) Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol 32:2087–2094PubMedCrossRef

Laird JR (2006) Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 13(Suppl 2):II30–II40PubMed

10.

Wyttenbach R, Gallino A, Alerci M et al (2004) Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110:1156–1161PubMedCrossRef

11.

Durand E, Raynaud JS, Bruneval P et al (2007) Magnetic resonance imaging of ruptured plaques in the rabbit with ultrasmall superparamagnetic particles of iron oxide. J Vasc Res 44:119–128PubMedCrossRef

12.

Ohlstein EH, Romanic AM, Clark LV et al (2000) Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery. Cardiovasc Res 47:759–768PubMedCrossRef

13.

Indolfi C, Torella D, Coppola C et al (2002) Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol 283:H760–H767PubMed

14.

Conde ID, Kleiman NS (2003) Arterial thrombosis for the interventional cardiologist: from adhesion molecules and coagulation factors to clinical therapeutics. Catheter Cardiovasc Interv 60:236–246PubMedCrossRef

15.

Heider P, Wildgruber MG, Weiss W, Berger HJ, Eckstein HH, Wolf O (2006) Role of adhesion molecules in the induction of restenosis after angioplasty in the lower limb. J Vasc Surg 43:969–977PubMedCrossRef

16.

Matter CM, Ma L, von LT et al (2006) Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice. Stroke 37:2625–2632

17.

Toutouzas K, Colombo A, Stefanadis C (2004) Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25:1679–1687PubMedCrossRef

18.

Schillinger M, Minar E (2004) Advances in vascular brachytherapy over the last 10 years: focus on femoropopliteal applications. J Endovasc Ther 11(Suppl 2):II180–II191PubMed

19.

Wyttenbach R, Corti R, Alerci M et al (2007) Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. Eur J Vasc Endovasc Surg 34:416–423PubMedCrossRef

20.

Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E (2006) Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up–prospective randomized study. Radiology 240:878–884PubMedCrossRef

21.

Bonvini R, Baumgartner I, Do DD et al (2003) Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 41:409–412PubMedCrossRef

22.

Krueger K, Bendel M, Zaehringer M et al (2006) Endovascular gamma irradiation for the prevention restenosis after angioplasty of femoropopliteal de novo stenoses. Eur Radiol 16:399–406PubMedCrossRef

23.

Sick PB, Brosteanu O, Niebauer J, Hehrlein C, Schuler G (2002) Neointima formation after stent implantation in an experimental model of restenosis: polytetrafluoroethylene-covered versus uncovered stainless steel stents. Heart Dis 4:18–25PubMedCrossRef

24.

Stankovic G, Colombo A, Presbitero P et al (2003) Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 108:37–42PubMedCrossRef

25.

Tepe G, Duda SH, Hanke H et al (1996) Covered stents for prevention of restenosis. Experimental and clinical results with different stent designs. Invest Radiol 31:223–229PubMedCrossRef

26.

Fattori R, Piva T (2003) Drug-eluting stents in vascular intervention. Lancet 361:247–249PubMedCrossRef

27.

Ribichini F, Joner M, Ferrero V et al (2007) Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol 50:176–185PubMedCrossRef

28.

Nuhrenberg TG, Voisard R, Fahlisch F et al (2005) Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J 19:246–248PubMed

29.

Bauriedel G, Schluckebier S, Hutter R et al (1998) Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol 18:1132–1139PubMed

30.

Perlman H, Maillard L, Krasinski K, Walsh K (1997) Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95:981–987PubMed

31.

Breuss JM, Cejna M, Bergmeister H et al (2002) Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 105:633–638PubMedCrossRef

32.

Niemann-Jonsson A, Ares MP, Yan ZQ et al (2001) Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler Thromb Vasc Biol 21:1909–1914PubMedCrossRef

33.

Giordano A, Avellino R, Ferraro P, Romano S, Corcione N, Romano MF (2006) Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis. Am J Physiol Heart Circ Physiol 290:H2459–H2465PubMedCrossRef

34.

Kopp CW, De MR (2004) Gene therapy approaches for the prevention of restenosis. Curr Vasc Pharmacol 2:183–189PubMedCrossRef

35.

Joye JD (2005) The clinical application of cryoplasty for infrainguinal peripheral arterial disease. Tech Vasc Interv Radiol 8:160–164PubMedCrossRef

36.

Bennett MR (1999) Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 41:361–368PubMedCrossRef

37.

Wilson PW, Heneghan AF, Haymet AD (2003) Ice nucleation in nature: supercooling point (SCP) measurements and the role of heterogeneous nucleation. Cryobiology 46:88–98PubMedCrossRef

38.

Soloff BL, Nagle WA, Moss AJ Jr, Henle KJ, Crawford JT (1987) Apoptosis induced by cold shock in vitro is dependent on cell growth phase. Biochem Biophys Res Commun 145:876–883PubMedCrossRef

39.

Berrada MS, Bischof JC (2001) Evaluation of freezing effects on human microvascular-endothelial cells (HMEC). Cryo Lett 22:353–366

40.

Tatsutani KN, Joye JD, Virmani R, Taylor MJ (2005) In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing. Cryo Lett 26:55–64

41.

Grassl ED, Bischof JC (2005) In vitro model systems for evaluation of smooth muscle cell response to cryoplasty. Cryobiology 50:162–173PubMedCrossRef

42.

Balasubramanian SK, Venkatasubramanian RT, Menon A, Bischof JC (2007) Thermal injury prediction during cryoplasty through in vitro characterization of smooth muscle cell biophysics and viability. Ann Biomed Eng 36:86–101

43.

Men-Chi H, Ravigururajan TS (2007) Biothermal modeling of post-cryoplasty atherosclerosis in restenotic patients. Cardiovasc Eng 7:7–16PubMedCrossRef

44.

Yiu WK, Cheng SW, Sumpio BE (2006) Vascular smooth muscle cell apoptosis induced by “supercooling” and rewarming. J Vasc Interv Radiol 17:1971–1977PubMedCrossRef

45.

Cheema AN, Nili N, Li CW et al (2003) Effects of intravascular cryotherapy on vessel wall repair in a balloon-injured rabbit iliac artery model. Cardiovasc Res 59:222–233PubMedCrossRef

46.

Karthik S, Tuite DJ, Nicholson AA et al (2007) Cryoplasty for arterial restenosis. Eur J Vasc Endovasc Surg 33:40–43PubMedCrossRef

47.

Samson RH, Showalter DP, Lepore MR Jr, Ames S (2006) Cryoplasty therapy of the superficial femoral and popliteal arteries: a single center experience. Vasc Endovascular Surg 40:446–450PubMedCrossRef

48.

Laird J, Jaff MR, Biamino G et al (2005) Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol 16:1067–1073PubMed

49.

Laird JR, Biamino G, McNamara T et al (2006) Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results. J Endovasc Ther 13(Suppl 2):II52–II59PubMed

50.

Das T, McNamara T, Gray B et al (2007) Cryoplasty therapy for limb salvage in patients with critical limb ischemia. J Endovasc Ther 14:753–762PubMedCrossRef

51.

Fava M, Loyola S, Polydorou A et al (2004) Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 15:1239–1243PubMed

52.

McCaslin JE, Macdonald S, Stansby G (2007) Cryoplasty for peripheral vascular disease. Cochrane Database Syst Rev CD005507

53.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5–S67PubMedCrossRef

54.

Schillinger M, Sabeti S, Dick P et al (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115:2745–2749PubMedCrossRef

55.

Ferreira M, Lanziotti L, Monteiro M et al (2007) Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 34:702–708PubMedCrossRef

56.

Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J (2002) Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 13:257–266PubMedCrossRef

57.

Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De LN (2008) Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 47:975–981

58.

Diehm N, Baumgartner I, Jaff M et al (2007) A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 28:798–805PubMedCrossRef

59.

AbuRahma AF, Hayes JD, Flaherty SK, Peery W (2007) Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg 46:965–970PubMedCrossRef

60.

Kudo T, Chandra FA, Ahn SS (2005) Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg 42:466–475PubMedCrossRef

61.

Duda SH, Bosiers M, Lammer J et al (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13:701–710PubMedCrossRef

62.

Tepe G (2006) Drug-eluting stents for infrainguinal occlusive disease: progress and challenges. Semin Vasc Surg 19:102–108PubMedCrossRef

63.

Tepe G, Zeller T, Albrecht T et al (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358:689–699PubMedCrossRef

64.

Abdellaoui A, Al-Khaffaf H (2007) C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg 34:18–22PubMedCrossRef

65.

Schillinger M, Haumer M, Schlerka G et al (2001) Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther 8:477–483PubMedCrossRef

66.

Wildgruber M, Weiss W, Berger H, Eckstein HH, Wolf O, Heider P (2007) Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery—a pilot study. Br J Radiol 80:430–436PubMedCrossRef

67.

Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Minar E (2003) Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther 10:288–297PubMedCrossRef

68.

Karthik S, Kessel DO (2007) Cryoplasty—Where is the evidence? Acta Chir Belg 107:500–503PubMed

Titel: Cryoplasty for the Prevention of Arterial Restenosis
verfasst von: Moritz G. Wildgruber
Hermann J. Berger
Publikationsdatum: 01.11.2008
Verlag: Springer-Verlag
Erschienen in: CardioVascular and Interventional Radiology / Ausgabe 6/2008
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-008-9364-y

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Cryoplasty for the Prevention of Arterial Restenosis

Abstract

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2008

Late Recurrence of a Hepatic Artery Aneurysm After Treatment Using an Endovascular Stent

Atlantoaxial Joint Synovial Cyst: Diagnosis and Percutaneous Treatment

A Novel Approach to Treatment of Unexpected Vertebroplasty Complication

Preoperative Transcatheter Selective Arterial Chemoembolization in Treatment of Unresectable Hepatoblastoma in Infants and Children

Necrosis and Apoptosis in Hepatocellular Carcinoma Following Low-Dose Versus High-Dose Preoperative Chemoembolization

Uterine Artery Embolization for Ureteric Obstruction Secondary to Fibroids

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Update Radiologie